Core Scientific, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $15.4M | $4.7M | $10.8M | $588.0K |
| Jun 2021 | $-136.7M | $-165.1M | $28.3M | $2.1M |
| Sep 2021 | $-45.1M | $-122.1M | $77.0M | $28.3M |
| Dec 2021 | $109.7M | $225.8M | $-116.1M | $7.9M |
| Mar 2022 | $-3.6M | $-136.8M | $133.2M | $25.8M |
| Jun 2022 | $144.9M | $39.6M | $105.3M | $111.0M |
| Sep 2022 | $-52.1M | $-57.3M | $5.2M | $29.8M |
| Dec 2022 | $116.0M | $-24.2M | $140.2M | $16.3M |
| Mar 2023 | $19.9M | $18.4M | $1.5M | $12.3M |
| Jun 2023 | $18.0M | $17.8M | $235.0K | $14.3M |
| Sep 2023 | $5.4M | $2.7M | $2.7M | $14.9M |
| Dec 2023 | $21.7M | $10.1M | $11.6M | $17.5M |
| Mar 2024 | $22.2M | $-9.7M | $31.9M | $-1.1M |
| Jun 2024 | $1.2M | $-1.9M | $3.1M | $8.5M |
| Sep 2024 | $5.7M | $-25.5M | $31.2M | $20.5M |
| Dec 2024 | $13.8M | $-15.0M | $28.8M | $24.0M |
| Mar 2025 | $-45.0M | $-129.0M | $84.0M | $16.2M |
| Jun 2025 | $34.0M | $-87.3M | $121.3M | $24.2M |
| Sep 2025 | $131.8M | $-112.7M | $244.5M | $29.9M |
| Dec 2025 | $157.5M | $-121.7M | $279.2M | $27.9M |
| Mar 2026 | $249.9M | $-139.3M | $389.2M | $17.8M |
| Jun 2026 | $-18.9M | $-583.9M | $565.0M | $18.2M |